Neuroscience

The global brain monitoring devices market is expected to grow at mid single digit CAGR of from 2019 to 2026 to reach $8,855.9 million by 2026.
Global Brain Monitoring Market is expected to reach USD 2.0 billion by 2024 from USD 1.2 billion in 2016, at a CAGR of 7.1% in the forecast period 2017 to 2024.
The Neural Network Software Market was valued at USD 8.3 billion in 2019 and is expected to reach USD 50.66 billion by 2025, at a CAGR of 35.2% over the forecast period 2020-2025.
The global Brain Computer Interface (BCI) market is valued at USD 125.21 million in 2018 and is expected to reach USD 283.04 million by the end of 2025, growing at a CAGR of 12.43% between 2019 and 2025.
In 2019, the global Brain Computer Interface (BCI) market size was USD 179 million and it is expected to reach USD 409.3 million by the end of 2026, with a CAGR of 12.4% during 2021-2026.
Over the next five years the Brain Computer Interface market will register a +11% CAGR in terms of revenue, the global market size will reach US$ 250.3 million by 2024, from US$ 154.1 million in 2019.
The global Brain Computer Interface (BCI) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.9% in the forecast period of 2020 to 2025 and will expected to reach USD 288.4 million by 2025, from USD 184.2 million in 2019.
Researchers at the University of California in San Francisco (UCSF) have used artificial intelligence (AI) technology to better interpret brain imaging to predict Alzheimer's.
There are more than 3.8 million women living in the United States with a history of invasive breast cancer, and 268,600 women will be newly diagnosed in 2019.
The American Cancer Society projects that 2,670 new cases of invasive breast cancer will be diagnosed in men in 2019, and about 500 men will die from it.
Owing to the rising demands for less invasive treatment procedures, the Europe market is expected to create a larger revenue pocket in the global market by 2023.
Invasive alien species pose a threat to native European biodiversity and cost the EU annual damages worth €12 billion as a result of IAS effects on human health, damaged infrastructure, and agricultural losses.
It's estimated that 268,600 new cases of invasive breast cancer will be diagnosed in women this year alone.
In 2019 the American Cancer Society estimates there will be 1.762 million new cases of invasive cancer diagnosed in the United States.
Over the next 30 years superbugs could kill 1.1 million people in North America and Australia and 1.3 million in Europe.
Invasive species and habitat loss are the biggest threats to Australian biodiversity.
In 2018, an estimated 266,120 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 63,960 new cases of non-invasive breast cancer.
Without strides in fighting antibiotic resistance, superbugs could kill 2.4 million people in North America, Europe and Australia over the next three decades.
The already high rates of biodiversity loss from habitat destruction, chemical pollution and invasive species will accelerate in the coming 30 years as a result of climate change and growing human populations.
One in eight women in the United States has a chance of being diagnosed with breast cancer and an estimated 250,000 new cases of invasive breast cancer are expected to be diagnosed in 2017.
Families of bacteria that pose the greatest threat to human health and most of these 12 superbugs have presence in India.
University of Liverpool researchers have developed a new antifungal drug to help in the treatment of life threatening invasive fungal infections such as invasive aspergillosis.
The Centers for Disease Control and Prevention and other leading medical experts agree that the widespread use of antibiotics for meat production threatens public health by contributing to the creation and spread of drug-resistant superbugs.

See full forecast

Last updated: 09 August 2020